Next Generation Sequencing Panel for Solid Tumor Cancers – A Test in Focus

Axel Grothey, M.D., discusses a new gene panel cancer test to help tailor chemotherapy to the individual patient based on the unique genomic signature of the patient’s tumor. This test scans specific regions in 50 genes known to affect tumor growth and response to chemotherapy. The test is now available to Mayo Clinic patients and to providers worldwide through Mayo Medical Laboratories.


Leave a Reply

Your email address will not be published. Required fields are marked *